Thea M. Mooij

4.6k total citations
21 papers, 725 citations indexed

About

Thea M. Mooij is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Thea M. Mooij has authored 21 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in Thea M. Mooij's work include Ovarian cancer diagnosis and treatment (9 papers), BRCA gene mutations in cancer (8 papers) and Reproductive Biology and Fertility (7 papers). Thea M. Mooij is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), BRCA gene mutations in cancer (8 papers) and Reproductive Biology and Fertility (7 papers). Thea M. Mooij collaborates with scholars based in Netherlands, United Kingdom and United States. Thea M. Mooij's co-authors include Flora E. van Leeuwen, Curt W. Burger, Matti A. Rookus, Marc van Beurden, R.I. Olivier, D.D.M. Braat, Rob E. Bernardus, Joke M. Schutte, Cornelis B. Lambalk and Marc J. van de Vijver and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and British Journal of Cancer.

In The Last Decade

Thea M. Mooij

19 papers receiving 705 citations

Peers

Countries citing papers authored by Thea M. Mooij

Since Specialization

Citations

This map shows the geographic impact of Thea M. Mooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thea M. Mooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thea M. Mooij more than expected).

Fields of papers citing papers by Thea M. Mooij

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thea M. Mooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thea M. Mooij. The network helps show where Thea M. Mooij may publish in the future.

Co-authorship network of co-authors of Thea M. Mooij

This figure shows the co-authorship network connecting the top 25 collaborators of Thea M. Mooij. A scholar is included among the top collaborators of Thea M. Mooij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thea M. Mooij. Thea M. Mooij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits 2022 ·JNCI Journal of the National Cancer Institute ·(unknown), Thea M. Mooij, Anouk Pijpe, Gabe S. Sonke, Marian J.E. Mourits, Nadine Andrieu, Antonis C. Antoniou, Douglas F. Easton, Christoph Engel, David E. Goldgar, Esther M. John, Karin Kast, Roger L. Milne, Håkan Olsson, Kelly‐Anne Phillips, Mary Beth Terry, John L. Hopper, Flora E. van Leeuwen, Matti A. Rookus	7
2	Abstract 4276: Oral contraceptive use and breast cancer risk: a cohort study of BRCA1 and BRCA2 mutation carriers 2017 ·Cancer Research ·(unknown), Håkan Olsson, Antonis C. Antoniou, Roger L. Milne, Kelly‐Anne Phillips, Nadine Andrieu, Douglas F. Easton, (unknown), Christoph Engel, Karin Kast, (unknown), Thea M. Mooij, John L. Hopper, F. van Leeuwen, Mary Beth Terry, Matti A. Rookus, (unknown)	0
3	Do BRCA1/2 mutation carriers have an earlier onset of natural menopause? 2016 ·Menopause The Journal of The North American Menopause Society ·Theodora C van Tilborg, Frank J. Broekmans, Anouk Pijpe, (unknown), Thea M. Mooij, Jan C. Oosterwijk, Senno Verhoef, E. Gómez, Wendy A. van Zelst-Stams, Muriel A. Adank, Christi J. van Asperen, Helena C. van Doorn, Theo A. van Os, (unknown), Matti A. Rookus, Margreet G.E.M. Ausems	18
4	Melanoma risk after ovarian stimulation for in vitro fertilization 2015 ·Human Reproduction ·(unknown), Alexandra W. van den Belt‐Dusebout, Michael Schaapveld, Thea M. Mooij, Curt W. Burger, Flora E. van Leeuwen, (unknown), R. Schats, Cornelis B. Lambalk, M. Kortman, Joop S.E. Laven, C.A.M. Jansen, Frans M. Helmerhorst, Ben J Cohlen, D.D.M. Braat, J Smeenk, Arnold Simons, F. van der Veen, J.L.H. Evers, P. A. van Dop	18
5	BRCA1/2 mutation carriers do not have earlier natural menopause compared to proven non-carriers: report from the Dutch hereditary breast and ovarian cancer study group (HEBON) 2014 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Madelon van Wely, Frank J. Broekmans, (unknown), Thea M. Mooij, Anouk Pijpe, JC Oosterwijk, (unknown), (unknown), Wendy A.G. van Zelst–Stams, Muriel A. Adank, C. J. van Asperen, Helena C. van Doorn, (unknown), Matti A. Rookus, Margreet G.E.M. Ausems	1
6	Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis 2014 ·International Journal of Cancer ·B.A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs, Margreet G.E.M. Ausems, J.M. Collée, Liesbeth Jansen, C. Marleen Kets, Kristien Keymeulen, Linetta B. Koppert, Hanne Meijers-Heijboer, Thea M. Mooij, Rob A.�E.�M. Tollenaar, Hans F. A. Vasen, (unknown), Maartje J. Hooning, Caroline Seynaeve	130
7	Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: A new hypothesis based on historical in vitro fertilisation treatment data 2014 ·European Journal of Cancer ·Inge M. Krul, (unknown), (unknown), Alexandra W. van den Belt‐Dusebout, Thea M. Mooij, Michael Hauptmann, Jos W. R. Twisk, Marieke J. Lambers, Peter G.A. Hompes, Curt W. Burger, Cornelis B. Lambalk, Flora E. van Leeuwen	6
8	Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis 2013 ·Human Reproduction ·(unknown), Flora E. van Leeuwen, Thea M. Mooij, Curt W. Burger, (unknown)	60
9	Factors associated with dizygotic twinning after IVF treatment with double embryo transfer 2012 ·Human Reproduction ·(unknown), Marieke J. Lambers, (unknown), Thea M. Mooij, Alexandra W. van den Belt‐Dusebout, Martijn W. Heymans, R. Schats, Peter G.A. Hompes, Annemieke Hoek, Curt W. Burger, Flora E. van Leeuwen, Cornelis B. Lambalk, (unknown)	6
10	120 BRCA1 Carriers and Oral Contraceptives – Risk-benefit Calculation on Breast and Ovarian Cancer 2012 ·European Journal of Cancer ·(unknown), M.A. Rookus, Thea M. Mooij, Anouk Pijpe, Flora E. van Leeuwen	0
11	Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort 2011 ·Human Reproduction ·Flora E. van Leeuwen, Helen Klip, Thea M. Mooij, (unknown), Cornelis B. Lambalk, M. Kortman, Joop S.E. Laven, C.A.M. Jansen, Frans M. Helmerhorst, Ben J Cohlen, Wim N.P. Willemsen, J Smeenk, Arnold Simons, F. van der Veen, J.L.H. Evers, P. A. van Dop, N.S. Macklon, Curt W. Burger	118
12	Maternal death related to IVF in the Netherlands 1984-2008 2010 ·Human Reproduction ·D.D.M. Braat, Joke M. Schutte, Rob E. Bernardus, Thea M. Mooij, Flora E. van Leeuwen	80
13	Risk of borderline and invasive ovarian tumors after ovarian stimulation for in vitro fertilization in a large Dutch cohort after 15 years of follow-up 2009 ·Gynecologic Oncology ·(unknown), (unknown), Thea M. Mooij, Flora E. van Leeuwen	3
14	A reduced size of the ovarian follicle pool is associated with an increased risk of a trisomic pregnancy in IVF-treated women 2009 ·Human Reproduction ·M.L. Haadsma, Thea M. Mooij, Henk Groen, Curt W. Burger, Cornelis B. Lambalk, Frank J. Broekmans, Flora E. van Leeuwen, K. Bouman, Annemieke Hoek, (unknown)	40
15	Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation 2009 ·Reproductive BioMedicine Online ·M.L. Haadsma, Henk Groen, Thea M. Mooij, Curt W. Burger, Frank J. Broekmans, Cornelis B. Lambalk, Flora E. van Leeuwen, (unknown)	31
16	Breast cancer risk in a nation-wide cohort of 25,152 subfertile women in the Netherlands 2008 ·Fertility and Sterility ·(unknown), Thea M. Mooij, Curt W. Burger, Flora E. van Leeuwen	2
17	No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study 2007 ·British Journal of Cancer ·Brenda Hermsen, R.I. Olivier, René H.M. Verheijen, Marc van Beurden, Joanne A. de Hullu, Leon F.A.G. Massuger, Curt W. Burger, Cecile T.M. Brekelmans, M J E Mourits, Geertruida H. de Bock, Katja N. Gaarenstroom, Hester H. van Boven, Thea M. Mooij, Matti A. Rookus	104
18	Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up 2004 ·British Journal of Cancer ·R.I. Olivier, Marc van Beurden, (unknown), Matti A. Rookus, Thea M. Mooij, Marc J. van de Vijver, Laura J. van’t Veer	92
19	‘Safety in primary schools: towards an accident-free school’: National implementation of a safety-policy strategy at primary schools in the Netherlands 2002 ·PubMed ·(unknown), (unknown), Thea M. Mooij	4
20	Short Reports 2000 ·(unknown), Thea M. Mooij, David J. Ball, (unknown), Virginia Routley, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact